In vitro cell culture models for the assessment of pulmonary drug disposition

Expert Opinion on Drug Metabolism & Toxicology
Jennifer L SportyCarsten Ehrhardt

Abstract

Aerosol administration of therapeutics to the respiratory system represents a significant opportunity for many classes of drugs, both small molecules and macromolecules, including recently engineered peptide and protein therapeutics. However, minimally invasive assessment of drug absorption mechanisms in vivo or from the isolated organ is prevented by the complex architecture of the lung. Thus, cell culture models of the bronchial and alveolar epithelial barriers have been developed for absorption mechanisms studies and are now widely used as in vitro screening tools. The aim of this article is to provide an update of the published work on various in vitro models of respiratory epithelium while emphasising the advantages and limitations of each model. This review summarises recent advances in the development and characterisation of in vitro cell culture models for drug disposition studies. A variety of cell culture systems for modelling the respiratory epithelium have been developed and are available to the scientific community. However, to allow their full exploitation in biopharmaceutical research, the currently available models have to be further characterised, particularly regarding their expression of transporter molecules...Continue Reading

References

Jan 15, 1976·International Journal of Cancer. Journal International Du Cancer·M LieberG Todaro
Jul 1, 1976·Proceedings of the Society for Experimental Biology and Medicine·L S Schanker, J A Burton
Aug 1, 1976·Environmental Health Perspectives·D G Kaufman
Feb 1, 1992·American Journal of Respiratory Cell and Molecular Biology·K C StoneJ D Crapo
Apr 1, 1990·In Vitro Cellular & Developmental Biology : Journal of the Tissue Culture Association·D C GruenertJ H Widdicombe
Aug 1, 1991·American Journal of Respiratory Cell and Molecular Biology·Y ChungP B Davis
Jun 1, 1989·Experimental Cell Research·B J ScholteJ Bijman
Sep 11, 1989·FEBS Letters·P N BlackS R Bloom
Sep 1, 1974·In Vitro·W H Douglas, M E Kaighn
Jan 1, 1983·The American Review of Respiratory Disease·T AhmedA Wanner
Jul 1, 1982·The American Journal of Physiology·B E Goodman, E D Crandall
Jan 1, 1994·American Journal of Respiratory Cell and Molecular Biology·A L CozensD C Gruenert
Jul 1, 1994·American Journal of Respiratory Cell and Molecular Biology·D ProudP E Ward
May 1, 1995·American Journal of Respiratory Cell and Molecular Biology·S I DantoE D Crandall
Dec 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·K A WikenheiserJ A Whitsett
Nov 1, 1995·In Vitro Cellular & Developmental Biology. Animal·T L NoahR B Devlin
Apr 1, 1996·American Journal of Respiratory Cell and Molecular Biology·M CortiJ H Harrison
Mar 1, 1996·British Journal of Clinical Pharmacology·E A EatonT Walle
Jan 1, 1997·Research in Veterinary Science·A SimeA Nolan
Oct 23, 1997·Microscopy Research and Technique·R W Godfrey
Feb 7, 1998·Pharmaceutical Research·P Artursson, R T Borchardt
May 1, 1998·American Journal of Respiratory and Critical Care Medicine·R J Mason, R G Crystal
Jul 14, 1998·In Vitro Cellular & Developmental Biology. Animal·L J GaliettaO Zegarra-Moran
Sep 1, 1999·Pharmaceutical Research·J ShenV H Lee
Nov 7, 2000·International Journal of Pharmaceutics·K A FosterK L Audus
Mar 14, 2001·American Journal of Respiratory Cell and Molecular Biology·L S King, P Agre
Jul 10, 2001·Pharmaceutical Research·K J KimE D Crandall
Feb 14, 2002·Proceedings of the National Academy of Sciences of the United States of America·Meshell D JohnsonLeland G Dobbs
Mar 7, 2002·American Journal of Physiology. Lung Cellular and Molecular Physiology·Zea BorokEdward D Crandall
Jul 12, 2002·Current Gene Therapy·S O'Dea, D J Harrison
Mar 6, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·Bogdan I FloreaGerrit Borchard

❮ Previous
Next ❯

Citations

Sep 17, 2009·Pharmaceutical Research·C Anthony HuntShahab Sheikh-Bahaei
Aug 6, 2011·Pharmaceutical Research·Leonie BaginskiCarsten Ehrhardt
Nov 9, 2012·Pharmaceutical Research·Berglind Eva BenediktsdóttirOlafur Baldursson
Sep 3, 2013·Prostaglandins & Other Lipid Mediators·Ayako FurugenKen Iseki
Feb 21, 2013·Journal of Aerosol Medicine and Pulmonary Drug Delivery·Peter MertesMarkus Kalberer
Jun 26, 2010·Science·Thomas H PetersenLaura E Niklason
Nov 25, 2011·International Journal of Nanomedicine·Simona MuraElias Fattal
Jul 31, 2012·Therapeutic Delivery·Johanna Jessica Salomon, Carsten Ehrhardt
Aug 8, 2013·Therapeutic Delivery·Mariam Ibrahim, Lucila Garcia-Contreras
Dec 23, 2010·Expert Opinion on Drug Delivery·Remigius U Agu, Michael I Ugwoke
Jan 9, 2013·Expert Opinion on Drug Metabolism & Toxicology·Xin LiuMichael S Roberts
Jun 1, 2014·Advanced Drug Delivery Reviews·Cristiane de Souza CarvalhoClaus-Michael Lehr
Jun 8, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Anthony J Hickey
Dec 2, 2009·Journal of Pharmaceutical Sciences·Cynthia Bosquillon
Dec 3, 2014·Advanced Drug Delivery Reviews·Marius HittingerClaus-Michael Lehr
Mar 20, 2012·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Johanna J SalomonCarsten Ehrhardt
Sep 29, 2009·International Journal of Pharmaceutics·Durga Kalyani PaturiAshim K Mitra
Dec 24, 2008·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Lenka HorálkováCarsten Ehrhardt
Aug 25, 2015·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Johanna J SalomonCarsten Ehrhardt
Mar 10, 2015·Molecular Pharmaceutics·Johanna J SalomonCarsten Ehrhardt
Feb 26, 2016·Expert Opinion on Drug Delivery·Sabrina NickelCarsten Ehrhardt
May 10, 2016·BioResearch Open Access·Sara ShafaieDavid Y S Chau
Nov 26, 2010·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Johanna J Salomon, Carsten Ehrhardt
Jul 3, 2013·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Victoria HutterCynthia Bosquillon
Jul 24, 2012·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·V HutterC Bosquillon
Apr 24, 2016·The Journal of Investigative Dermatology·Parth PatelKarthik Krishnamurthy
Sep 3, 2011·Molecular Pharmaceutics·Frederic TewesAnne Marie Healy
Dec 17, 2016·Experimental Lung Research·Felix R JimenezPaul R Reynolds

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V
Ben Forbes, Carsten Ehrhardt
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
Fergus ManfordBen Forbes
© 2022 Meta ULC. All rights reserved